336 related articles for article (PubMed ID: 27310888)
21. Preferential Secretion of Thymic Stromal Lymphopoietin (TSLP) by Terminally Differentiated Esophageal Epithelial Cells: Relevance to Eosinophilic Esophagitis (EoE).
Chandramouleeswaran PM; Shen D; Lee AJ; Benitez A; Dods K; Gambanga F; Wilkins BJ; Merves J; Noah Y; Toltzis S; Yearley JH; Spergel JM; Nakagawa H; Malefyt Rd; Muir AB; Wang ML
PLoS One; 2016; 11(3):e0150968. PubMed ID: 26992000
[TBL] [Abstract][Full Text] [Related]
22. Antifibrotic Effects of the Thiazolidinediones in Eosinophilic Esophagitis Pathologic Remodeling: A Preclinical Evaluation.
Nhu QM; Hsieh L; Dohil L; Dohil R; Newbury RO; Kurten R; Moawad FJ; Aceves SS
Clin Transl Gastroenterol; 2020 Apr; 11(4):e00164. PubMed ID: 32352681
[TBL] [Abstract][Full Text] [Related]
23. Regulatory mechanisms of Th2 cytokine-induced eotaxin-3 production in bronchial epithelial cells: possible role of interleukin 4 receptor and nuclear factor-kappaB.
Kobayashi I; Yamamoto S; Nishi N; Tsuji K; Imayoshi M; Inada S; Ichiamaru T; Hamasaki Y
Ann Allergy Asthma Immunol; 2004 Oct; 93(4):390-7. PubMed ID: 15521376
[TBL] [Abstract][Full Text] [Related]
24. SOCS-1 and SOCS-3 inhibit IL-4 and IL-13 induced activation of Eotaxin-3/CCL26 gene expression in HEK293 cells.
Hebenstreit D; Luft P; Schmiedlechner A; Duschl A; Horejs-Hoeck J
Mol Immunol; 2005 Feb; 42(3):295-303. PubMed ID: 15589317
[TBL] [Abstract][Full Text] [Related]
25. Upregulation of interleukin-4 receptor by interferon-gamma: enhanced interleukin-4-induced eotaxin-3 production in airway epithelium.
Yamamoto S; Kobayashi I; Tsuji K; Nishi N; Muro E; Miyazaki M; Zaitsu M; Inada S; Ichimaru T; Hamasaki Y
Am J Respir Cell Mol Biol; 2004 Oct; 31(4):456-62. PubMed ID: 15231490
[TBL] [Abstract][Full Text] [Related]
26. Markers of eosinophilic inflammation for diagnosis of eosinophilic esophagitis and proton pump inhibitor-responsive esophageal eosinophilia: a prospective study.
Dellon ES; Speck O; Woodward K; Covey S; Rusin S; Gebhart JH; Chen X; Woosley JT; Shaheen NJ
Clin Gastroenterol Hepatol; 2014 Dec; 12(12):2015-22. PubMed ID: 24993367
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical differentiation of eosinophilic esophageal myositis from eosinophilic esophagitis.
Sato H; Nakajima N; Hasegawa G; Kawata Y; Sato Y; Suzuki K; Honma T; Terai S
J Gastroenterol Hepatol; 2017 Jan; 32(1):106-113. PubMed ID: 27262491
[TBL] [Abstract][Full Text] [Related]
28. Elevated IL-33 expression is associated with pediatric eosinophilic esophagitis, and exogenous IL-33 promotes eosinophilic esophagitis development in mice.
Judd LM; Heine RG; Menheniott TR; Buzzelli J; O'Brien-Simpson N; Pavlic D; O'Connor L; Al Gazali K; Hamilton O; Scurr M; Collison AM; Mattes J; Allen KJ; Giraud AS
Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(1):G13-25. PubMed ID: 26514775
[TBL] [Abstract][Full Text] [Related]
29. Differential regulation of eotaxin-1/CCL11 and eotaxin-3/CCL26 production by the TNF-alpha and IL-4 stimulated human lung fibroblast.
Rokudai A; Terui Y; Kuniyoshi R; Mishima Y; Mishima Y; Aizu-Yokota E; Sonoda Y; Kasahara T; Hatake K
Biol Pharm Bull; 2006 Jun; 29(6):1102-9. PubMed ID: 16755001
[TBL] [Abstract][Full Text] [Related]
30. Esophageal epithelial and mesenchymal cross-talk leads to features of epithelial to mesenchymal transition in vitro.
Muir AB; Lim DM; Benitez AJ; Modayur Chandramouleeswaran P; Lee AJ; Ruchelli ED; Spergel JM; Wang ML
Exp Cell Res; 2013 Apr; 319(6):850-9. PubMed ID: 23237990
[TBL] [Abstract][Full Text] [Related]
31. Solute carrier family 9, subfamily A, member 3 (SLC9A3)/sodium-hydrogen exchanger member 3 (NHE3) dysregulation and dilated intercellular spaces in patients with eosinophilic esophagitis.
Zeng C; Vanoni S; Wu D; Caldwell JM; Wheeler JC; Arora K; Noah TK; Waggoner L; Besse JA; Yamani AN; Uddin J; Rochman M; Wen T; Chehade M; Collins MH; Mukkada VA; Putnam PE; Naren AP; Rothenberg ME; Hogan SP
J Allergy Clin Immunol; 2018 Dec; 142(6):1843-1855. PubMed ID: 29729938
[TBL] [Abstract][Full Text] [Related]
32. Regulation of eotaxin-3/CC chemokine ligand 26 expression by T helper type 2 cytokines in human colonic myofibroblasts.
Takahashi K; Imaeda H; Fujimoto T; Ban H; Bamba S; Tsujikawa T; Sasaki M; Fujiyama Y; Andoh A
Clin Exp Immunol; 2013 Aug; 173(2):323-31. PubMed ID: 23607908
[TBL] [Abstract][Full Text] [Related]
33. Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism.
Mishra A; Rothenberg ME
Gastroenterology; 2003 Nov; 125(5):1419-27. PubMed ID: 14598258
[TBL] [Abstract][Full Text] [Related]
34. Eosinophilic esophagitis: epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatment.
Kagalwalla AF; Akhtar N; Woodruff SA; Rea BA; Masterson JC; Mukkada V; Parashette KR; Du J; Fillon S; Protheroe CA; Lee JJ; Amsden K; Melin-Aldana H; Capocelli KE; Furuta GT; Ackerman SJ
J Allergy Clin Immunol; 2012 May; 129(5):1387-1396.e7. PubMed ID: 22465212
[TBL] [Abstract][Full Text] [Related]
35. Targeting granulocyte-macrophage colony-stimulating factor in epithelial and vascular remodeling in experimental eosinophilic esophagitis.
McNamee EN; Biette KA; Hammer J; Harris R; Miyazawa H; Lee JJ; Furuta GT; Masterson JC
Allergy; 2017 Aug; 72(8):1232-1242. PubMed ID: 27926989
[TBL] [Abstract][Full Text] [Related]
36. Eotaxin-3 (CCL26) Expression in Human Pancreatic Myofibroblasts.
Fujimoto T; Imaeda H; Takahashi K; Nishida A; Shioya M; Inatomi O; Bamba S; Shiomi H; Tani M; Andoh A
Pancreas; 2016 Mar; 45(3):420-4. PubMed ID: 26418908
[TBL] [Abstract][Full Text] [Related]
37. TGF-β1-induced PAI-1 contributes to a profibrotic network in patients with eosinophilic esophagitis.
Rawson R; Yang T; Newbury RO; Aquino M; Doshi A; Bell B; Broide DH; Dohil R; Kurten R; Aceves SS
J Allergy Clin Immunol; 2016 Sep; 138(3):791-800.e4. PubMed ID: 27212082
[TBL] [Abstract][Full Text] [Related]
38. 17β-Estradiol protects the esophageal epithelium from IL-13-induced barrier dysfunction and remodeling.
Wheeler JC; Vanoni S; Zeng C; Waggoner L; Yang Y; Wu D; Uddin J; Karns R; Kottyan L; Mukkada V; Rothenberg ME; Hogan SP
J Allergy Clin Immunol; 2019 Jun; 143(6):2131-2146. PubMed ID: 30578870
[TBL] [Abstract][Full Text] [Related]
39. PDE4 inhibitors have no effect on eotaxin expression in human primary bronchial epithelial cells.
Paplińska-Goryca M; Chazan R; Grubek-Jaworska H
Acta Biochim Pol; 2012; 59(3):371-5. PubMed ID: 22946025
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-13 upregulates eotaxin expression in airway epithelial cells by a STAT6-dependent mechanism.
Matsukura S; Stellato C; Georas SN; Casolaro V; Plitt JR; Miura K; Kurosawa S; Schindler U; Schleimer RP
Am J Respir Cell Mol Biol; 2001 Jun; 24(6):755-61. PubMed ID: 11415942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
